1. Home
  2. ETON vs EFT Comparison

ETON vs EFT Comparison

Compare ETON & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • EFT
  • Stock Information
  • Founded
  • ETON 2017
  • EFT 2004
  • Country
  • ETON United States
  • EFT United States
  • Employees
  • ETON N/A
  • EFT N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • EFT Finance Companies
  • Sector
  • ETON Health Care
  • EFT Finance
  • Exchange
  • ETON Nasdaq
  • EFT Nasdaq
  • Market Cap
  • ETON 388.3M
  • EFT 327.7M
  • IPO Year
  • ETON 2018
  • EFT N/A
  • Fundamental
  • Price
  • ETON $17.31
  • EFT $12.08
  • Analyst Decision
  • ETON Strong Buy
  • EFT
  • Analyst Count
  • ETON 3
  • EFT 0
  • Target Price
  • ETON $29.67
  • EFT N/A
  • AVG Volume (30 Days)
  • ETON 329.2K
  • EFT 100.8K
  • Earning Date
  • ETON 08-07-2025
  • EFT 01-01-0001
  • Dividend Yield
  • ETON N/A
  • EFT 10.63%
  • EPS Growth
  • ETON N/A
  • EFT N/A
  • EPS
  • ETON N/A
  • EFT 1.73
  • Revenue
  • ETON $58,181,000.00
  • EFT N/A
  • Revenue This Year
  • ETON $105.25
  • EFT N/A
  • Revenue Next Year
  • ETON $40.84
  • EFT N/A
  • P/E Ratio
  • ETON N/A
  • EFT $7.62
  • Revenue Growth
  • ETON 85.40
  • EFT N/A
  • 52 Week Low
  • ETON $4.47
  • EFT $11.10
  • 52 Week High
  • ETON $21.48
  • EFT $13.44
  • Technical
  • Relative Strength Index (RSI)
  • ETON 61.58
  • EFT 43.69
  • Support Level
  • ETON $17.02
  • EFT $12.00
  • Resistance Level
  • ETON $17.77
  • EFT $12.24
  • Average True Range (ATR)
  • ETON 0.69
  • EFT 0.08
  • MACD
  • ETON 0.03
  • EFT 0.01
  • Stochastic Oscillator
  • ETON 78.80
  • EFT 63.16

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest

Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.

Share on Social Networks: